Download PDF
Semin Respir Crit Care Med 2014; 35(02): 166-180
DOI: 10.1055/s-0034-1371526
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

High-Resolution Computed Tomography of the Pulmonary Manifestations of Connective Tissue Diseases

J. Jacob
1   Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
,
A. Nair
1   Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
,
David M. Hansell
1   Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
25 March 2014 (online)

    Permissions and Reprints

Abstract

Pulmonary disease is common in patients with connective tissue disease (CTD) and confers significant morbidity and mortality. High-resolution computed tomography (HRCT) provides considerable information regarding the distribution and severity of thoracic disease in CTD. Different anatomical compartments of the lung can be simultaneously affected in a given individual. Furthermore, lung injury may not be solely related to the underlying CTD, but may be caused by treatment or infections. Finally, the risk of developing cancer is increased in patients with certain CTDs. In this review, the HRCT manifestations of CTD are initially discussed with respect to the different compartments involved, followed by a description of the spectrum of pulmonary disease commonly occurring in specific CTDs.

Keywords

computed tomography - imaging - connective tissue diseases
 

  • References

  • 1 Lee J, Dhillon N, Pope J. All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford) 2013; 52 (5) 905-909
    CrossrefPubMedGoogle Scholar
  • 2 Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171 (1) 111-116
    CrossrefPubMedGoogle Scholar
  • 3 Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978; 298 (17) 934-939
    CrossrefPubMedGoogle Scholar
  • 4 Garland LH, Cochrane AL. Results of an international test in chest roentgenogram interpretation. J Am Med Assoc 1952; 149 (7) 631-634
    CrossrefPubMedGoogle Scholar
  • 5 Garland LH. Studies on the accuracy of diagnostic procedures. Am J Roentgenol Radium Ther Nucl Med 1959; 82 (1) 25-38
    PubMedGoogle Scholar
  • 6 Tuddenham WJ. Problems in perception in chest roentgenology: facts and fallacies. Radiol Clin North Am 1963; 1: 277-289
    PubMedGoogle Scholar
  • 7 Gabbay E, Tarala R, Will R , et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997; 156 (2, Pt 1) 528-535
    CrossrefPubMedGoogle Scholar
  • 8 Wells AU. Histopathologic diagnosis in diffuse lung disease: an ailing gold standard. Am J Respir Crit Care Med 2004; 170 (8) 828-829
    CrossrefPubMedGoogle Scholar
  • 9 Grenier P, Chevret S, Beigelman C, Brauner MW, Chastang C, Valeyre D. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 1994; 191 (2) 383-390
    CrossrefPubMedGoogle Scholar
  • 10 Bradley B, Branley HM, Egan JJ , et al; British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 (Suppl. 05) v1-v58
    CrossrefPubMedGoogle Scholar
  • 11 American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165 (2) 277-304
    CrossrefPubMedGoogle Scholar
  • 12 Tansey D, Wells AU, Colby TV , et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44 (6) 585-596
    CrossrefPubMedGoogle Scholar
  • 13 Bouros D, Wells AU, Nicholson AG , et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165 (12) 1581-1586
    CrossrefPubMedGoogle Scholar
  • 14 Hartman TE, Swensen SJ, Hansell DM , et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217 (3) 701-705
    CrossrefPubMedGoogle Scholar
  • 15 Johkoh T, Müller NL, Cartier Y , et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211 (2) 555-560
    CrossrefPubMedGoogle Scholar
  • 16 Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18 (2) 136-147
    CrossrefPubMedGoogle Scholar
  • 17 Kobayashi T, Satoh K, Ohkawa M, Satoh A. Multiple rheumatoid nodules with rapid thin-walled cavity formation producing pneumothorax. J Thorac Imaging 2005; 20 (1) 47-49
    CrossrefPubMedGoogle Scholar
  • 18 MacDonald SLS, Rubens MB, Hansell DM , et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221 (3) 600-605
    CrossrefPubMedGoogle Scholar
  • 19 Johkoh T, Müller NL, Colby TV , et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225 (1) 199-204
    CrossrefPubMedGoogle Scholar
  • 20 Kim TS, Lee KS, Chung MP , et al. Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings. AJR Am J Roentgenol 1998; 171 (6) 1645-1650
    CrossrefPubMedGoogle Scholar
  • 21 Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998; 158 (4) 1286-1293
    CrossrefPubMedGoogle Scholar
  • 22 Silva CI, Müller NL, Hansell DM, Lee KS, Nicholson AG, Wells AU. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247 (1) 251-259
    CrossrefPubMedGoogle Scholar
  • 23 Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991; 18 (10) 1520-1528
    PubMedGoogle Scholar
  • 24 Launay D, Remy-Jardin M, Michon-Pasturel U , et al. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 2006; 33 (9) 1789-1801
    PubMedGoogle Scholar
  • 25 Kim DS, Collard HR, King TEJ. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006; 3 (4) 285-292
    CrossrefPubMedGoogle Scholar
  • 26 Müller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT-pathologic correlation. Radiology 1986; 160 (3) 585-588
    CrossrefPubMedGoogle Scholar
  • 27 Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H. Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 1992; 182 (2) 337-342
    CrossrefPubMedGoogle Scholar
  • 28 Webb WR, Stein MG, Finkbeiner WE, Im J-G, Lynch DA, Gamsu G. Normal and diseased isolated lungs: high-resolution CT. Radiology 1988; 166 (1, Pt 1): 81-87
    CrossrefPubMedGoogle Scholar
  • 29 Hunninghake GW, Lynch DA, Galvin JR , et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124 (4) 1215-1223
    CrossrefPubMedGoogle Scholar
  • 30 Westcott JL, Cole SR. Traction bronchiectasis in end-stage pulmonary fibrosis. Radiology 1986; 161 (3) 665-669
    CrossrefPubMedGoogle Scholar
  • 31 Lynch DA, Godwin JD, Safrin S , et al; Idiopathic Pulmonary Fibrosis Study Group. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172 (4) 488-493
    CrossrefPubMedGoogle Scholar
  • 32 Elliot TL, Lynch DA, Newell Jr JD , et al. High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr 2005; 29 (3) 339-345
    CrossrefPubMedGoogle Scholar
  • 33 Sumikawa H, Johkoh T, Ichikado K , et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients. Radiology 2006; 241 (1) 258-266
    CrossrefPubMedGoogle Scholar
  • 34 Wells AU, Cullinan P, Hansell DM , et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994; 149 (6) 1583-1590
    CrossrefPubMedGoogle Scholar
  • 35 Renzoni E, Rottoli P, Coviello G, Perari MG, Galeazzi M, Vagliasindi M. Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease. Clin Rheumatol 1997; 16 (6) 570-577
    CrossrefPubMedGoogle Scholar
  • 36 Park JH, Kim DS, Park IN , et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175 (7) 705-711
    CrossrefPubMedGoogle Scholar
  • 37 Kim EJ, Collard HR, King Jr TE. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009; 136 (5) 1397-1405
    CrossrefPubMedGoogle Scholar
  • 38 Kim EJ, Elicker BM, Maldonado F , et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010; 35 (6) 1322-1328
    CrossrefPubMedGoogle Scholar
  • 39 Nakamura Y, Suda T, Kaida Y , et al. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases. Respir Med 2012; 106 (8) 1164-1169
    CrossrefPubMedGoogle Scholar
  • 40 Tung KT, Wells AU, Rubens MB, Kirk JM, du Bois RM, Hansell DM. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993; 48 (4) 334-338
    CrossrefPubMedGoogle Scholar
  • 41 Primack SL, Hartman TE, Hansell DM, Müller NL. End-stage lung disease: CT findings in 61 patients. Radiology 1993; 189 (3) 681-686
    CrossrefPubMedGoogle Scholar
  • 42 Nishimura K, Izumi T, Kitaichi M, Nagai S, Itoh H. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases. Chest 1993; 104 (4) 1149-1155
    CrossrefPubMedGoogle Scholar
  • 43 Swensen SJ, Aughenbaugh GL, Myers JL. Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology 1997; 205 (1) 229-234
    CrossrefPubMedGoogle Scholar
  • 44 Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. Chest 1999; 116 (5) 1168-1174
    CrossrefPubMedGoogle Scholar
  • 45 Hunninghake GW, Zimmerman MB, Schwartz DA , et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164 (2) 193-196
    CrossrefPubMedGoogle Scholar
  • 46 Flaherty KR, Thwaite EL, Kazerooni EA , et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58 (2) 143-148
    CrossrefPubMedGoogle Scholar
  • 47 Lee KS, Kullnig P, Hartman TE, Müller NL. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR Am J Roentgenol 1994; 162 (3) 543-546
    CrossrefPubMedGoogle Scholar
  • 48 Müller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR Am J Roentgenol 1990; 154 (5) 983-987
    CrossrefPubMedGoogle Scholar
  • 49 Ujita M, Renzoni EA, Veeraraghavan S, Wells AU, Hansell DM. Organizing pneumonia: perilobular pattern at thin-section CT. Radiology 2004; 232 (3) 757-761
    CrossrefPubMedGoogle Scholar
  • 50 Bouchardy LM, Kuhlman JE, Ball Jr WC, Hruban RH, Askin FB, Siegelman SS. CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 1993; 17 (3) 352-357
    CrossrefPubMedGoogle Scholar
  • 51 Nishimura K, Itoh H. High-resolution computed tomographic features of bronchiolitis obliterans organizing pneumonia. Chest 1992; 102 (1, Suppl): 26S-31S
    CrossrefPubMedGoogle Scholar
  • 52 Arakawa H, Kurihara Y, Niimi H, Nakajima Y, Johkoh T, Nakamura H. Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high-resolution CT findings in 81 patients. AJR Am J Roentgenol 2001; 176 (4) 1053-1058
    CrossrefPubMedGoogle Scholar
  • 53 Lee JW, Lee KS, Lee HY , et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol 2010; 195 (4) 916-922
    CrossrefPubMedGoogle Scholar
  • 54 Johkoh T, Ichikado K, Akira M , et al. Lymphocytic interstitial pneumonia: follow-up CT findings in 14 patients. J Thorac Imaging 2000; 15 (3) 162-167
    CrossrefPubMedGoogle Scholar
  • 55 Silva CI, Flint JDA, Levy RD, Müller NL. Diffuse lung cysts in lymphoid interstitial pneumonia: high-resolution CT and pathologic findings. J Thorac Imaging 2006; 21 (3) 241-244
    CrossrefPubMedGoogle Scholar
  • 56 Suda T, Kaida Y, Nakamura Y , et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009; 103 (6) 846-853
    CrossrefPubMedGoogle Scholar
  • 57 Parambil JG, Myers JL, Ryu JH. Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest 2006; 130 (2) 553-558
    CrossrefPubMedGoogle Scholar
  • 58 Parambil JG, Myers JL, Aubry MC, Ryu JH. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest 2007; 132 (1) 50-57
    CrossrefPubMedGoogle Scholar
  • 59 Tomiyama N, Müller NL, Johkoh T , et al. Acute respiratory distress syndrome and acute interstitial pneumonia: comparison of thin-section CT findings. J Comput Assist Tomogr 2001; 25 (1) 28-33
    CrossrefPubMedGoogle Scholar
  • 60 Primack SL, Hartman TE, Ikezoe J, Akira M, Sakatani M, Müller NL. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993; 188 (3) 817-820
    CrossrefPubMedGoogle Scholar
  • 61 Ichikado K, Suga M, Müller NL , et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 2002; 165 (11) 1551-1556
    CrossrefPubMedGoogle Scholar
  • 62 Johkoh T, Müller NL, Taniguchi H , et al. Acute interstitial pneumonia: thin-section CT findings in 36 patients. Radiology 1999; 211 (3) 859-863
    CrossrefPubMedGoogle Scholar
  • 63 Zrour SH, Touzi M, Bejia I , et al. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine 2005; 72 (1) 41-47
    PubMedGoogle Scholar
  • 64 Park IN, Kim DS, Shim TS , et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132 (1) 214-220
    CrossrefPubMedGoogle Scholar
  • 65 Lynch DA, Travis WD, Müller NL , et al. Idiopathic interstitial pneumonias: CT features. Radiology 2005; 236 (1) 10-21
    CrossrefPubMedGoogle Scholar
  • 66 Vourlekis JS, Brown KK, Cool CD , et al. Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore) 2000; 79 (6) 369-378
    CrossrefPubMedGoogle Scholar
  • 67 Ichikado K, Johkoh T, Ikezoe J , et al. Acute interstitial pneumonia: high-resolution CT findings correlated with pathology. AJR Am J Roentgenol 1997; 168 (2) 333-338
    CrossrefPubMedGoogle Scholar
  • 68 Murata K, Itoh H, Todo G , et al. Centrilobular lesions of the lung: demonstration by high-resolution CT and pathologic correlation. Radiology 1986; 161 (3) 641-645
    CrossrefPubMedGoogle Scholar
  • 69 Despaux J, Manzoni P, Toussirot E, Augé B, Cedoz JP, Wendling D. Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum Engl Ed 1998; 65 (7–9) 453-461
    PubMedGoogle Scholar
  • 70 Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982; 6 (3) 437-444
    CrossrefPubMedGoogle Scholar
  • 71 Visscher DW, Myers JL. Bronchiolitis: the pathologist's perspective. Proc Am Thorac Soc 2006; 3 (1) 41-47
    CrossrefPubMedGoogle Scholar
  • 72 Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr 1999; 23 (6) 941-948
    CrossrefPubMedGoogle Scholar
  • 73 Tanaka N, Kim JS, Newell JD , et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004; 232 (1) 81-91
    CrossrefPubMedGoogle Scholar
  • 74 Pipavath SJ, Lynch DA, Cool C, Brown KK, Newell JD. Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol 2005; 185 (2) 354-363
    CrossrefPubMedGoogle Scholar
  • 75 Geddes DM, Corrin B, Brewerton DA, Davies RJ, Turner-Warwick M. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med 1977; 46 (184) 427-444
    PubMedGoogle Scholar
  • 76 Hill CL, Nguyen AM, Roder D, Roberts-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003; 62 (8) 728-731
    CrossrefPubMedGoogle Scholar
  • 77 Huang YL, Chen YJ, Lin MW , et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol 2009; 161 (4) 854-860
    CrossrefPubMedGoogle Scholar
  • 78 Bernatsky S, Boivin JF, Joseph L , et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005; 52 (5) 1481-1490
    CrossrefPubMedGoogle Scholar
  • 79 Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40 (4) 761-768
    CrossrefPubMedGoogle Scholar
  • 80 Yamada T, Nakajima A, Inoue E , et al. Incidence of malignancy in Japanese patients with rheumatoid arthritis. Rheumatol Int 2011; 31 (11) 1487-1492
    CrossrefPubMedGoogle Scholar
  • 81 Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995; 76 (5) 910-914
    CrossrefPubMedGoogle Scholar
  • 82 Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008; 10 (2) R45
    CrossrefPubMedGoogle Scholar
  • 83 Ramsey-Goldman R, Mattai SA, Schilling E , et al. Increased risk of malignancy in patients with systemic lupus erythematosus. J Investig Med 1998; 46 (5) 217-222
    PubMedGoogle Scholar
  • 84 Hesselstrand R, Scheja A, Åkesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998; 57 (11) 682-686
    CrossrefPubMedGoogle Scholar
  • 85 Bin J, Bernatsky S, Gordon C , et al. Lung cancer in systemic lupus erythematosus. Lung Cancer 2007; 56 (3) 303-306
    CrossrefPubMedGoogle Scholar
  • 86 Bernatsky S, Ramsey-Goldman R, Clarke AE. Malignancy in systemic lupus erythematosus: what have we learned?. Best Pract Res Clin Rheumatol 2009; 23 (4) 539-547
    CrossrefPubMedGoogle Scholar
  • 87 Valesini G, Priori R, Bavoillot D , et al. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol 1997; 24 (12) 2376-2380
    PubMedGoogle Scholar
  • 88 Kassan SS, Thomas TL, Moutsopoulos HM , et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89 (6) 888-892
    CrossrefPubMedGoogle Scholar
  • 89 Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999; 42 (8) 1765-1772
    CrossrefPubMedGoogle Scholar
  • 90 Tonami H, Matoba M, Kuginuki Y , et al. Clinical and imaging findings of lymphoma in patients with Sjögren syndrome. J Comput Assist Tomogr 2003; 27 (4) 517-524
    CrossrefPubMedGoogle Scholar
  • 91 Franquet T, Giménez A, Monill JM, Díaz C, Geli C. Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997; 169 (3) 655-658
    CrossrefPubMedGoogle Scholar
  • 92 Kelly CA, Foster H, Pal B , et al. Primary Sjögren's syndrome in north east England: a longitudinal study. Br J Rheumatol 1991; 30: 437-442
    CrossrefPubMedGoogle Scholar
  • 93 Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2007; 28 (1) 255-269 , x
    CrossrefPubMedGoogle Scholar
  • 94 Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990; 112 (9) 682-698
    CrossrefPubMedGoogle Scholar
  • 95 Quadrelli SA, Alvarez C, Arce SC , et al. Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus 2009; 18 (12) 1053-1060
    CrossrefPubMedGoogle Scholar
  • 96 Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995; 129 (3) 510-515
    CrossrefPubMedGoogle Scholar
  • 97 Prabu A, Patel K, Yee CS , et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 2009; 48 (12) 1506-1511
    CrossrefPubMedGoogle Scholar
  • 98 Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1978; 64 (6) 998-1004
    CrossrefPubMedGoogle Scholar
  • 99 Trell E, Lindström C. Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis 1971; 30 (4) 390-400
    CrossrefPubMedGoogle Scholar
  • 100 Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 1984; 19 (1) 16-22
    CrossrefPubMedGoogle Scholar
  • 101 Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol 1998; 71 (850) 1018-1020
    CrossrefPubMedGoogle Scholar
  • 102 Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW ; Medical College of Wisconsin Lung Transplant Group. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest 1998; 113 (5) 1250-1256
    CrossrefPubMedGoogle Scholar
  • 103 Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999; 14 (4) 270-278
    CrossrefPubMedGoogle Scholar
  • 104 Haimovici JB, Trotman-Dickenson B, Halpern EF , et al; Massachusetts General Hospital Lung Transplantation Program. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Acad Radiol 1997; 4 (5) 327-334
    CrossrefPubMedGoogle Scholar
  • 105 Moore NR, Scott JP, Flower CD, Higenbottam TW. The relationship between pulmonary artery pressure and pulmonary artery diameter in pulmonary hypertension. Clin Radiol 1988; 39 (5) 486-489
    CrossrefPubMedGoogle Scholar
  • 106 Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008; 249 (3) 1042-1049
    CrossrefPubMedGoogle Scholar
  • 107 Huggins J, Doelken P, Sahn S. The unexpandable lung. F1000 Med Rep 2012; 2: 77
    PubMedGoogle Scholar
  • 108 Martens J, Demedts M, Vanmeenen MT, Dequeker J. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983; 84 (2) 170-175
    PubMedGoogle Scholar
  • 109 Sahn SA. Immunologic diseases of the pleura. Clin Chest Med 1985; 6 (1) 83-102
    PubMedGoogle Scholar
  • 110 Brown KK. Rheumatoid lung disease. Proc Am Thorac Soc 2007; 4 (5) 443-448
    CrossrefPubMedGoogle Scholar
  • 111 Kim DS. Interstitial lung disease in rheumatoid arthritis: recent advances. Curr Opin Pulm Med 2006; 12 (5) 346-353
    CrossrefPubMedGoogle Scholar
  • 112 Skare TL, Nakano I, Escuissiato DL, Batistetti R, Rodrigues TdeO, Silva MB. Pulmonary changes on high-resolution computed tomography of patients with rheumatoid arthritis and their association with clinical, demographic, serological and therapeutic variables. Rev Bras Reumatol 2011; 51 (4) 325-330 , 336–337
    PubMedGoogle Scholar
  • 113 Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology 1994; 193 (2) 375-382
    CrossrefPubMedGoogle Scholar
  • 114 Mori S, Cho I, Koga Y, Sugimoto M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 2008; 35 (8) 1513-1521
    PubMedGoogle Scholar
  • 115 Hassan WU, Keaney NP, Holland CD, Kelly CA. High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54 (4) 308-310
    CrossrefPubMedGoogle Scholar
  • 116 Cortet B, Perez T, Roux N , et al. Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1997; 56 (10) 596-600
    CrossrefPubMedGoogle Scholar
  • 117 Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998; 157 (5, Pt 1) 1658-1665
    CrossrefPubMedGoogle Scholar
  • 118 Terasaki H, Fujimoto K, Hayabuchi N, Ogoh Y, Fukuda T, Müller NL. Respiratory symptoms in rheumatoid arthritis: relation between high resolution CT findings and functional impairment. Radiat Med 2004; 22 (3) 179-185
    PubMedGoogle Scholar
  • 119 Devouassoux G, Cottin V, Lioté H , et al; Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM”O”P). Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J 2009; 33 (5) 1053-1061
    CrossrefPubMedGoogle Scholar
  • 120 Lee HK, Kim DS, Yoo B , et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005; 127 (6) 2019-2027
    CrossrefPubMedGoogle Scholar
  • 121 Biederer J, Schnabel A, Muhle C, Gross WL, Heller M, Reuter M. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004; 14 (2) 272-280
    CrossrefPubMedGoogle Scholar
  • 122 Hakala M, Pääkkö P, Huhti E, Tarkka M, Sutinen S. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990; 9 (4) 452-460
    CrossrefPubMedGoogle Scholar
  • 123 Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997; 56 (8) 463-469
    CrossrefPubMedGoogle Scholar
  • 124 Akira M, Ishikawa H, Yamamoto S. Drug-induced pneumonitis: thin-section CT findings in 60 patients. Radiology 2002; 224 (3) 852-860
    CrossrefPubMedGoogle Scholar
  • 125 Camus P, Bonniaud P, Fanton A, Camus C, Baudaun N, Foucher P. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med 2004; 25 (3) 479-519 , vi
    CrossrefPubMedGoogle Scholar
  • 126 Tzelepis GE, Toya SP, Moutsopoulos HM. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 2008; 31 (1) 11-20
    CrossrefPubMedGoogle Scholar
  • 127 Golden MR, Katz RS, Balk RA, Golden HE. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol 1995; 22 (6) 1043-1047
    PubMedGoogle Scholar
  • 128 Tachikawa R, Tomii K, Ueda H , et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 2012; 83 (1) 20-27
    CrossrefPubMedGoogle Scholar
  • 129 Tsuchiya Y, Takayanagi N, Sugiura H , et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011; 37 (6) 1411-1417
    CrossrefPubMedGoogle Scholar
  • 130 Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20 (5) 1245-1259
    CrossrefPubMedGoogle Scholar
  • 131 Cannon GW. Methotrexate pulmonary toxicity. Rheum Dis Clin North Am 1997; 23 (4) 917-937
    CrossrefPubMedGoogle Scholar
  • 132 Savage RL, Highton J, Boyd IW, Chapman P. Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports. Intern Med J 2006; 36 (3) 162-169
    CrossrefPubMedGoogle Scholar
  • 133 Sakai F, Noma S, Kurihara Y , et al. Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features. Mod Rheumatol 2005; 15 (3) 173-179
    CrossrefPubMedGoogle Scholar
  • 134 Hargreaves MR, Mowat AG, Benson MK. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax 1992; 47 (8) 628-633
    CrossrefPubMedGoogle Scholar
  • 135 Hilliquin P, Renoux M, Perrot S, Puéchal X, Menkès CJ. Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis. Br J Rheumatol 1996; 35 (5) 441-445
    CrossrefPubMedGoogle Scholar
  • 136 Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15 (2) 373-381
    CrossrefPubMedGoogle Scholar
  • 137 Arakawa H, Yamasaki M, Kurihara Y, Yamada H, Nakajima Y. Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imaging 2003; 18 (4) 231-236
    CrossrefPubMedGoogle Scholar
  • 138 Meyers JL. Pathology of drug-induced lung disease. In: Katzenstein AA, Askin FB, , eds. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. 3rd ed. Philadelphia, PA: Saunders; 1997: 81-111
    Google Scholar
  • 139 Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38 (9) 1261-1265
    CrossrefPubMedGoogle Scholar
  • 140 Hagiwara K, Sato T, Takagi-Kobayashi S, Hasegawa S, Shigihara N, Akiyama O. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. J Rheumatol 2007; 34 (5) 1151-1154
    PubMedGoogle Scholar
  • 141 Thavarajah K, Wu P, Rhew EJ, Yeldandi AK, Kamp DW. Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med 2009; 103 (5) 661-669
    CrossrefPubMedGoogle Scholar
  • 142 Franquet T. High-resolution CT of lung disease related to collagen vascular disease. Radiol Clin North Am 2001; 39 (6) 1171-1187
    CrossrefPubMedGoogle Scholar
  • 143 Dawson JK, Goodson NG, Graham DR, Lynch MP. Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford) 2000; 39 (12) 1320-1325
    CrossrefPubMedGoogle Scholar
  • 144 Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron P-Y. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993; 188 (2) 499-506
    CrossrefPubMedGoogle Scholar
  • 145 Goldin JG, Lynch DA, Strollo DC , et al; Scleroderma Lung Study Research Group. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 2008; 134 (2) 358-367
    CrossrefPubMedGoogle Scholar
  • 146 Desai SR, Veeraraghavan S, Hansell DM , et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232 (2) 560-567
    CrossrefPubMedGoogle Scholar
  • 147 Kim DS, Yoo B, Lee JS , et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19 (2) 121-127
    PubMedGoogle Scholar
  • 148 Shah RM, Jimenez S, Wechsler R. Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis. J Thorac Imaging 2007; 22 (2) 120-124
    CrossrefPubMedGoogle Scholar
  • 149 Chan TYK, Hansell DM, Rubens MB, du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax 1997; 52 (3) 265-270
    CrossrefPubMedGoogle Scholar
  • 150 Bhalla M, Silver RM, Shepard JA, McLoud TC. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol 1993; 161 (2) 269-272
    CrossrefPubMedGoogle Scholar
  • 151 Muir TE, Tazelaar HD, Colby TV, Myers JL. Organizing diffuse alveolar damage associated with progressive systemic sclerosis. Mayo Clin Proc 1997; 72 (7) 639-642
    CrossrefPubMedGoogle Scholar
  • 152 Bridges AJ, Hsu KC, Dias-Arias AA, Chechani V. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol 1992; 19 (7) 1136-1140
    PubMedGoogle Scholar
  • 153 Abu-Shakra M, Guillemin F, Lee P. Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum 1994; 24 (1) 29-39
    PubMedGoogle Scholar
  • 154 Marie I, Levesque H, Ducrotté P , et al. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 2001; 96 (1) 77-83
    CrossrefPubMedGoogle Scholar
  • 155 Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996; 8 (6) 569-575
    CrossrefPubMedGoogle Scholar
  • 156 Pandey AK, Wilcox P, Mayo JR , et al. Oesophageal dilatation on high-resolution CT chest in systemic sclerosis: what does it signify?. J Med Imaging Radiat Oncol 2011; 55 (6) 551-555
    CrossrefPubMedGoogle Scholar
  • 157 McLaughlin V, Humbert M, Coghlan G, Nash P, Steen V. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis. Rheumatology (Oxford) 2009; 48 (Suppl. 03) iii25-iii31
    PubMedGoogle Scholar
  • 158 Hachulla E, de Groote P, Gressin V , et al; Itinér AIR-Sclérodermie Study Group. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009; 60 (6) 1831-1839
    CrossrefPubMedGoogle Scholar
  • 159 Wells AU, Steen V, Valentini G. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology (Oxford) 2009; 48 (Suppl. 03) iii40-iii44
    PubMedGoogle Scholar
  • 160 Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003; 123 (2) 344-350
    CrossrefPubMedGoogle Scholar
  • 161 Nolan RL, McAdams HP, Sporn TA, Roggli VL, Tapson VF, Goodman PC. Pulmonary cholesterol granulomas in patients with pulmonary artery hypertension: chest radiographic and CT findings. AJR Am J Roentgenol 1999; 172 (5) 1317-1319
    CrossrefPubMedGoogle Scholar
  • 162 Tashkin DP, Elashoff R, Clements PJ , et al; Scleroderma Lung Study Research Group. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354 (25) 2655-2666
    CrossrefPubMedGoogle Scholar
  • 163 Goh NSL, Desai SR, Veeraraghavan S , et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177 (11) 1248-1254
    CrossrefPubMedGoogle Scholar
  • 164 Moore OA, Goh N, Corte T , et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford) 2013; 52 (1) 155-160
    CrossrefPubMedGoogle Scholar
  • 165 Kim JS, Lee KS, Koh EM, Kim SY, Chung MP, Han J. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000; 24 (1) 9-18
    CrossrefPubMedGoogle Scholar
  • 166 Sant SM, Doran M, Fenelon HM, Breatnach ES. Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol 1997; 15 (5) 507-513
    PubMedGoogle Scholar
  • 167 Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996; 166 (2) 301-307
    CrossrefPubMedGoogle Scholar
  • 168 Wiedemann HP, Matthay RA. Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imaging 1992; 7 (2) 1-18
    CrossrefPubMedGoogle Scholar
  • 169 Weinrib L, Sharma OP, Quismorio Jr FP. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20 (1) 48-56
    CrossrefPubMedGoogle Scholar
  • 170 Jacobsen S, Petersen J, Ullman S , et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998; 17 (6) 468-477
    CrossrefPubMedGoogle Scholar
  • 171 Murin S, Wiedemann HP, Matthay RA. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 1998; 19 (4) 641-665 , viii
    CrossrefPubMedGoogle Scholar
  • 172 Keane MP, Lynch III JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55 (2) 159-166
    CrossrefPubMedGoogle Scholar
  • 173 Oki H, Aoki T, Saito K , et al. Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome. Eur J Radiol 2012; 81 (6) 1335-1339
    CrossrefPubMedGoogle Scholar
  • 174 Swigris JJ, Fischer A, Gillis J, Meehan RT, Brown KK. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest 2008; 133 (1) 271-280
    CrossrefPubMedGoogle Scholar
  • 175 Cervera R, Bucciarelli S, Plasín MA , et al; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum On Antiphospholipid Antibodies). Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun 2009; 32 (3–4) 240-245
    CrossrefPubMedGoogle Scholar
  • 176 Carette S, Macher AM, Nussbaum A, Plotz PH. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum 1984; 14 (1) 52-59
    CrossrefPubMedGoogle Scholar
  • 177 Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997; 76 (3) 192-202
    CrossrefPubMedGoogle Scholar
  • 178 Good Jr JT, King TE, Antony VB, Sahn SA. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983; 84 (6) 714-718
    CrossrefPubMedGoogle Scholar
  • 179 Levin DC. Proper interpretation of pulmonary roentgen changes in systemic lupus erythematosus. Am J Roentgenol Radium Ther Nucl Med 1971; 111 (3) 510-517
    CrossrefPubMedGoogle Scholar
  • 180 Grigor R, Edmonds J, Lewkonia R, Bresnihan B, Hughes GR. Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 1978; 37 (2) 121-128
    CrossrefPubMedGoogle Scholar
  • 181 Bernstein RM, Morgan SH, Chapman J , et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) 1984; 289 (6438) 151-152
    CrossrefPubMedGoogle Scholar
  • 182 Kalluri M, Sahn SA, Oddis CV , et al. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest 2009; 135 (6) 1550-1556
    CrossrefPubMedGoogle Scholar
  • 183 Kang EH, Lee EB, Shin KC , et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 2005; 44 (10) 1282-1286
    CrossrefPubMedGoogle Scholar
  • 184 Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Ichikado K, Nakamura H. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 1996; 11 (4) 250-259
    CrossrefPubMedGoogle Scholar
  • 185 Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol 1997; 169 (1) 83-87
    CrossrefPubMedGoogle Scholar
  • 186 Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 1999; 210 (2) 333-338
    CrossrefPubMedGoogle Scholar
  • 187 Bonnefoy O, Ferretti G, Calaque O , et al. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol 2004; 49 (3) 235-244
    CrossrefPubMedGoogle Scholar
  • 188 Rice AJ, Wells AU, Bouros D , et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am J Clin Pathol 2003; 119 (5) 709-714
    CrossrefPubMedGoogle Scholar
  • 189 Kameda H, Takeuchi T. Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositis. Endocr Metab Immune Disord Drug Targets 2006; 6 (4) 409-415
    CrossrefPubMedGoogle Scholar
  • 190 Koreeda Y, Higashimoto I, Yamamoto M , et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010; 49 (5) 361-369
    CrossrefPubMedGoogle Scholar
  • 191 Takato H, Waseda Y, Watanabe S , et al. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia—with or without PM/DM. Respir Med 2013; 107 (1) 128-133
    CrossrefPubMedGoogle Scholar
  • 192 Buchbinder R, Hill CL. Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 2002; 4 (5) 415-426
    CrossrefPubMedGoogle Scholar
  • 193 Bodolay E, Szekanecz Z, Dévényi K , et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 2005; 44 (5) 656-661
    CrossrefPubMedGoogle Scholar
  • 194 Kim EA, Lee KS, Johkoh T , et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002; 22 (Spec No, Suppl 1): S151-S165
    CrossrefPubMedGoogle Scholar
  • 195 Prakash UB. Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998; 19 (4) 733-746 , ix
    CrossrefPubMedGoogle Scholar
  • 196 Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999; 42 (5) 899-909
    CrossrefPubMedGoogle Scholar
  • 197 Bennett RM, O'Connell DJ. Mixed connective tisssue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum 1980; 10 (1) 25-51
    CrossrefPubMedGoogle Scholar
  • 198 Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010; 138 (2) 251-256
    CrossrefPubMedGoogle Scholar
  • 199 Kinder BW, Collard HR, Koth L , et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 2007; 176 (7) 691-697
    CrossrefPubMedGoogle Scholar
  • 200 Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011; 140 (5) 1292-1299
    CrossrefPubMedGoogle Scholar
  • 201 Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999; 17 (5) 615-620
    PubMedGoogle Scholar
  • 202 Suda T, Kono M, Nakamura Y , et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med 2010; 104 (10) 1527-1534
    CrossrefPubMedGoogle Scholar
  • 203 Corte TJ, Copley SJ, Desai SR , et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012; 39 (3) 661-668
    CrossrefPubMedGoogle Scholar
  • 204 Mukae H, Ishimoto H, Sakamoto N , et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 2009; 136 (5) 1341-1347
    CrossrefPubMedGoogle Scholar
  • 205 Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K. Pulmonary lesions associated with Sjögren's syndrome: radiographic and CT findings. Br J Radiol 2003; 76 (912) 880-884
    CrossrefPubMedGoogle Scholar
  • 206 Ramos-Casals M, Solans R, Rosas J , et al; GEMESS Study Group. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008; 87 (4) 210-219
    CrossrefPubMedGoogle Scholar
  • 207 Koyama M, Johkoh T, Honda O , et al. Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 2001; 16 (4) 290-296
    CrossrefPubMedGoogle Scholar
  • 208 Lohrmann C, Uhl M, Warnatz K , et al. High-resolution CT imaging of the lung for patients with primary Sjogren's syndrome. Eur J Radiol 2004; 52 (2) 137-143
    CrossrefPubMedGoogle Scholar
  • 209 Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest 2006; 130 (5) 1489-1495
    CrossrefPubMedGoogle Scholar
  • 210 Yamadori I, Fujita J, Bandoh S , et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002; 22 (3) 89-92
    CrossrefPubMedGoogle Scholar
  • 211 Ito I, Nagai S, Kitaichi M , et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005; 171 (6) 632-638
    CrossrefPubMedGoogle Scholar
  • 212 Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 2001; 16 (4) 282-289
    CrossrefPubMedGoogle Scholar
  • 213 Johkoh T, Müller NL, Pickford HA , et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212 (2) 567-572
    CrossrefPubMedGoogle Scholar
  • 214 Váróczy L, Gergely L, Zeher M, Szegedi G, Illés Á. Malignant lymphoma-associated autoimmune diseases—a descriptive epidemiological study. Rheumatol Int 2002; 22 (6) 233-237
    CrossrefPubMedGoogle Scholar
  • 215 Ichikawa Y, Kinoshita M, Koga T, Oizumi K, Fujimoto K, Hayabuchi N. Lung cyst formation in lymphocytic interstitial pneumonia: CT features. J Comput Assist Tomogr 1994; 18 (5) 745-748
    CrossrefPubMedGoogle Scholar
  • 216 Honda O, Johkoh T, Ichikado K , et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol 1999; 173 (1) 71-74
    CrossrefPubMedGoogle Scholar
  • 217 Nicholson AG, Wotherspoon AC, Diss TC , et al. Reactive pulmonary lymphoid disorders. Histopathology 1995; 26 (5) 405-412
    PubMedGoogle Scholar
  • 218 Jeong YJ, Lee KS, Chung MP , et al. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr 2004; 28 (6) 776-781
    CrossrefPubMedGoogle Scholar